Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

In the next issue of PPM, pain experts will share their vision for what’s ahead in pain practice. Here are a few highlights.
Opioid misuse has seen record lows in high schoolers, while marijuana use remains stable for 2018.
An Idaho study points to the continued need for prescriber-pharmacist communication especially when multiple opioid prescribers are involved.
Chronic pain patients who use food banks may have a fear of running out of food.
The GeoPain app allows patients to be clear and precise when describing their pain.
FDA approves Dsuvia (sufentanil) sublingual tablets.
In scope-changing regulatory news, President Trump used the one-year anniversary of declaring a national opioid public health emergency to sign into law the “Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act,” or for short, the SUPPORT for Patients and Communities Act).
FDA has awarded five grants to advance the development of pediatric medical devices.
The rate of opioid use disorder among pregnant women has quadrupled over a 15-year span from 1999 to 2014.
Buprenorphine uptake increases as more physicians receive waivers.
FDA approves third migraine prevention medication in the new CGRP class: Lilly's Emgality.
FDA REMS now apply to immediate-release opioid analgesics.
Nearly $200 million in new CDC funds will go to territories, tribes, NGOs, and states to help support opioid awareness and response programs.
close X